Do you need frequent kidney tests while taking Cosentyx (secukinumab)?
Cosentyx (secukinumab) is not known for requiring routine, frequent kidney function monitoring in the way some other medications can. In general, monitoring needs are driven by the patient’s overall health and comorbidities rather than a specific, mandatory schedule for renal labs solely because of Cosentyx.
What do Cosentyx prescribing information–style safety statements typically focus on?
For secukinumab, clinical attention usually centers on infection risk and other class-related safety monitoring rather than a standard requirement for regular kidney function tests. Kidney monitoring is therefore more likely to be considered if you already have chronic kidney disease, abnormal baseline kidney function, or other conditions that affect the kidneys.
When would kidney monitoring be recommended anyway?
Clinicians often check kidney function more closely when patients have factors that increase risk, such as baseline chronic kidney disease, dehydration or other causes of acute kidney injury risk, use of kidney-relevant medications, or past lab abnormalities. In these cases, monitoring frequency is usually set by the kidney condition itself, not by Cosentyx alone.
What should patients ask their clinician before starting?
Patients who are concerned about kidneys should ask whether they need baseline labs (and how often to repeat them) based on their medical history. That conversation matters most if they have reduced kidney function, diabetes, uncontrolled hypertension, recurrent infections, or they take other drugs that can affect the kidneys.
Practical takeaway
If you have normal kidney function and no kidney-related risk factors, frequent kidney function monitoring specifically because of Cosentyx is typically not required. If you have existing kidney disease or other risk factors, your clinician may still recommend periodic kidney labs based on your overall risk profile.
Sources: None provided.